The National Breast Cancer Coalition (NBCC) commends U.S. Rep. Peter King (R-NY2) and U.S. Rep. Kathy Castor (D-FL14) for introducing […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
The National Breast Cancer Coalition (NBCC) commends U.S. Rep. Peter King (R-NY2) and U.S. Rep. Kathy Castor (D-FL14) for introducing […]
The National Breast Cancer Coalition has always taken the position that a large percentage of toxic treatment for breast cancer […]
WASHINGTON, D.C., March 8, 2018 — On Tuesday, March 6th, the U.S. Food and Drug Administration (FDA) announced approval of a direct-to-consumer genetic […]
Dr. Gregory Hannon of Cold Spring Harbor, and Dr. H. Kim Lyerly, of Duke University School of Medicine, receive grant […]
Dr. Paul Ewald, University of Louisville and Dr. Vladimir Belyi, Robert Wood Johnson Medical School to receive grant through the […]
Dr. Paul Spellman and Dr. Joe Gray of Oregon Health and Science University receive grants through the generous support of […]
